Company intelligence / Profile preview

GQ Bio Therapeutics

Hamburg, Hamburg, Germanygq-biotx.com ↗

Ownership: Private
Development stage: Phase 2

Overview

GQ Bio’s lead gene therapy candidate, PCRX‑201, demonstrated sustained improvements in knee pain, stiffness, and function through two years after local administration in a large Phase 1 study for osteoarthritis of the knee. The product was well tolerated with no major adverse events. A randomized double-blind Phase 2 trial is being initiated by Pacira. Other pipeline assets remain preclinical

Therapeutic areas: Rheumatology
Modalities: Gene therapy vectors (high-capacity adenoviral/HCAd)
Industry: Biotech

Drug pipeline

1 asset

enekinragene inzadenovec

Phase 2

Indications: Osteoarthritis of the knee

Partnerships

Exothera SA/NV – manufacturing process development partnership for scalable production using bioreactorsFlexion Therapeutics – acquired lead program from GQ Bio before Flexion itself was acquired by PaciraAcademic collaborations in Wallonia region mentioned but not specified

Beyond the preview

Go deeper on GQ Bio Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GQ Bio Therapeutics.